Robert M. Califf, M.D. Commissioner of Food and Drugs - FDA | Official Website
Robert M. Califf, M.D. Commissioner of Food and Drugs - FDA | Official Website
This is an increase over the number of companies cited in the previous year.
The citations in the county include:
- Written procedures are not established for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.
- Representative samples are not taken of each shipment of each lot of components for testing or examination.
- Testing and release of drug product for distribution do not include appropriate laboratory determination of satisfactory conformance to the identity and strength of each active ingredient prior to release.
The company cited had to take regulatory and/or administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Continental Manufacturing Chemist, Inc. | Drugs | 05/10/2023 | Written procedures not established/followed |
Continental Manufacturing Chemist, Inc. | Drugs | 05/10/2023 | Representative Samples |
Continental Manufacturing Chemist, Inc. | Drugs | 05/10/2023 | Testing and release for distribution |
Continental Manufacturing Chemist, Inc. | Veterinary | 05/10/2023 | Written procedures not established/followed |
Continental Manufacturing Chemist, Inc. | Veterinary | 05/10/2023 | Representative Samples |
Continental Manufacturing Chemist, Inc. | Veterinary | 05/10/2023 | Testing and release for distribution |